Phenobarbital: The Durable Sentinel of Neurology

Phenobarbital, first marketed in 1912 as Luminal, is the oldest anticonvulsant still in active clinical use. While newer, “sexier” drugs like Levetiracetam or Lacosamide have taken the spotlight in modern Indian hospitals, Phenobarbital remains an indispensable tool for public health. Its low cost, long duration of action, and proven efficacy in neonatal seizures make it a “World Health Organization (WHO) Essential Medicine.” However, as a member of the barbiturate class, it carries a legacy of danger—including profound cognitive suppression and a withdrawal syndrome that can be far more lethal than that of benzodiazepines.

This nineteenth installment provides an exhaustive analysis of Phenobarbital in the Indian context for 2026.

---

1. Substance Profile & Classification

• Generic Name: Phenobarbital (also known as Phenobarbitone)
• Chemical Class: Barbiturate
• Therapeutic Class: Anticonvulsant / Sedative-Hypnotic
• Indian Legal Status:
  • Schedule H Drug: In India, Phenobarbital is classified under Schedule H of the Drugs and Cosmetics Rules. It can only be sold against a valid prescription from a Registered Medical Practitioner.
  • Regulatory Monitoring: While many barbiturates were moved to the highly restricted Schedule X in the past, Phenobarbital remains under Schedule H due to its vital role in epilepsy management, though its records are audited strictly by state drug controllers.

---

2. Market Availability and Pricing in India (May 2026)

Phenobarbital is available across India in tablet (30mg, 60mg), syrup, and injectable forms.

A. PMBJP (Jan Aushadhi Kendra) Unbranded Prices

The Jan Aushadhi initiative is the primary provider of Phenobarbital for rural and low-income epilepsy patients, offering life-long treatment for a few rupees a month.

Medicine Name	Unit Size	Jan Aushadhi Price (INR)
Phenobarbitone Tablets IP 30mg	30’s	₹15.94
Phenobarbitone Tablets IP 60 mg	30’s	₹26.25

B. Branded Market Prices (Commercial Sector)

The brand “Gardenal” has been a household name in India for decades.

Brand Name	Manufacturer	Strength	Approx. Market Price (INR)
Gardenal	Abbott India	30mg (15 Tabs)	₹32.00
Gardenal-60	Abbott India	60mg (15 Tabs)	₹55.00
Luminal	Sun Pharma	30mg (10 Tabs)	₹28.00
Phenogard	Neon Laboratories	200mg/ml (Inj)	₹18.00
Gardenal Syrup	Abbott India	20mg/5ml (100ml)	₹85.00

---

3. Clinical Pharmacology: The GABA-A Opener

Mechanism of Action

Phenobarbital belongs to the barbiturate class. Unlike benzodiazepines, which increase the frequency of GABA channel opening, barbiturates increase the duration of each opening.

• Direct Agonism: At high doses, Phenobarbital can directly open the GABA channel even without GABA present, making it much more dangerous in overdose than benzos.
• Broad Spectrum: It effectively suppresses the spread of seizure activity and raises the threshold for neuronal firing.

Pharmacokinetics: The 100-Hour Half-Life

• Absorption: Slow but nearly complete.
• Half-life: Exceptionally long. In Indian adults, the mean half-life is 79 to 100 hours. In neonates, it can extend to 140 hours.
• Steady State: It takes nearly 2 to 3 weeks of daily dosing to reach a stable level in the blood.
• Metabolism: Primarily in the liver. It is a potent inducer of liver enzymes (CYP450), meaning it can cause other drugs (like oral contraceptives or blood thinners) to break down much faster, making them ineffective.

---

4. Clinical Context: The “First-Line” for Neonates

In 2026, Phenobarbital remains the first-line choice for neonatal seizures in India.

• Why? It is highly effective in the developing brain and has a long track record of safety for short-term acute use in hospitals.
• Hyperbilirubinemia: Historically used to treat neonatal jaundice, though modern phototherapy has largely replaced this in Indian NICUs.

---

5. Euphoria and Misuse: The “Stoning” Effect

Euphoria Profile

• The “Stone” High: Phenobarbital does not produce the “relaxed” euphoria of Alprazolam. Instead, it creates a heavy, slow, “stoned” state where physical movement and mental processing are significantly delayed.
• Depressive Aura: Users often report a feeling of emotional “flatness” or apathy.

Misuse Trends in India

1. Diverted Epilepsy Meds: In certain rural belts of Punjab and Haryana, diverted Phenobarbital tablets are used as a cheap alternative to intoxicants.
2. Alcohol Substitution: Because it acts on similar receptors as alcohol, it is sometimes misused to suppress alcohol withdrawal, but the risk of fatal respiratory arrest is extremely high.

---

6. Critical Risks: Cognitive Decline and Lethality

A. Cognitive Suppression

Long-term use of Phenobarbital, especially in children, is associated with a decrease in IQ, memory problems, and behavioral issues (hyperactivity or irritability). This is the primary reason Indian neurologists try to move patients to newer drugs when possible.

B. The “Narrow Therapeutic Window”

There is a very small difference between a “healing” dose and a “toxic” dose of Phenobarbital. This makes it a high-risk drug for accidental overdose.

---

7. Toxicity and Overdose

Overdose Signs

• The “Barbiturate Burn”: Severe blisters on the skin can occur in deep coma cases.
• Severe Respiratory Depression.
• Hypothermia (Body temperature drops).
• Renal Failure.

Emergency Action: There is NO ANTIDOTE for Phenobarbital. Treatment in Indian ICUs involves mechanical ventilation, forced alkaline diuresis (to flush the drug through the kidneys), and sometimes charcoal hemoperfusion.

---

8. Addiction and Withdrawal: The Seizure Danger

Stopping Phenobarbital suddenly is one of the most dangerous things a patient can do.

• Withdrawal Seizures: Within 24-72 hours of stopping, a patient can enter Status Epilepticus (life-threatening continuous seizures).
• Delirium: Similar to alcohol DTs, it can cause severe hallucinations and tremors.
• Tapering: In 2026, the standard tapering protocol in India involves reducing the dose by 10-15% every month, given its long half-life.

---

9. Legal Status and Public Health

• Schedule H Strictness: While it is a “cheap” drug, any pharmacy selling Phenobarbital without a stamp and record on the prescription is liable for a license suspension.
• 2026 Regulatory View: The Indian government maintains it on the Essential Medicines List to ensure affordability for the millions of Indians living with epilepsy.

---

10. Harm Reduction Strategies

• The “Vitamin” Rule: Long-term Phenobarbital use can lead to Vitamin D and Folate deficiency. Indian patients are often co-prescribed supplements to prevent bone loss and anemia.
• Avoid Pregnancy Complications: Phenobarbital is associated with a higher risk of birth defects. Women of childbearing age in India should discuss non-barbiturate alternatives with their neurologist.
• Zero Alcohol: Mixing Phenobarbital with even a small amount of alcohol can be fatal.

---

Next in the Series: Part 20: Pentobarbital – The Veterinary Sedative and the Ethics of End-of-Life Care

Disclaimer: This series is for educational and harm-reduction purposes only. Phenobarbital is a potent medical drug with serious long-term side effects. Never stop taking this medication without strict medical supervision.